抗HCC-1抗体(Anti-HCC-1, Human, Goat-Poly, Biotin antibody)

掲載日情報:2021/01/28 現在Webページ番号:27577

HCC-1に対する抗体(Anti-HCC-1, Human, Goat-Poly, Biotin )です。
本製品は研究用です。研究用以外には使用できません。

価格

[在庫・価格 :2024年05月18日 00時00分現在]

※ 表示されている納期は弊社に在庫が無く、取り寄せた場合の納期目安となります。
詳細 商品名
  • 商品コード
  • メーカー
  • 包装
  • 価格
  • 在庫
  • 法規制等
納期 文献数
Anti-HCC-1, Human, Goat-Poly, Biotin
10日程度 ※ 表示されている納期は弊社に在庫がなく、取り寄せた場合の目安納期となります。 1
説明文
マッチドペア:Human CCL14a/HCC-1 サンドイッチELISAの検出用抗体として利用可能,補足用抗体として#MAB3241,スタンダードとして#324-HC-010を用いる。
別名:CCL14a,HCC-1
Genbank No: 6358
Protein Accession No: Q16627
法規制等
保存条件 -20℃ 法規備考
抗原種 Human 免疫動物 Goat クラス IgG 標識 Biotin
交差性 Human 適用 ELISA,Western Blot
クロナリティ Polyclonal フォーマット 性状 Antigen Affinity Purified 吸収処理
掲載カタログ

製品記事
関連記事 R&D Systems(R&Dシステムズ)社 ELISA用ペア抗体を使用したELISA 構築ガイド

[在庫・価格 :2024年05月18日 00時00分現在]

※ 表示されている納期は弊社に在庫が無く、取り寄せた場合の納期目安となります。

Anti-HCC-1, Human, Goat-Poly, Biotin

文献数: 1

説明文 マッチドペア:Human CCL14a/HCC-1 サンドイッチELISAの検出用抗体として利用可能,補足用抗体として#MAB3241,スタンダードとして#324-HC-010を用いる。
別名:CCL14a,HCC-1
Genbank No: 6358
Protein Accession No: Q16627
法規制等
保存条件 -20℃ 法規備考
抗原種 Human 免疫動物 Goat
交差性 Human 適用 ELISA,Western Blot
標識 Biotin 性状 Antigen Affinity Purified
吸収処理 クラス IgG
クロナリティ Polyclonal フォーマット
掲載カタログ

製品記事
関連記事 R&D Systems(R&Dシステムズ)社 ELISA用ペア抗体を使用したELISA 構築ガイド



目次に戻る

Product Details

Species ReactivityHuman
LabelBiotin
ImmunogenE. coli-derived recombinant human CCL14a/HCC-1 (R&D Systems, Catalog # 324-HC)Thr20-Asn93Accession # Q16627
SourcePolyclonal Goat IgG
PurificationAntigen Affinity-purified
SpecificityDetects human CCL14a/HCC-1 in ELISAs and Western blots. In sandwich immunoassays, less than 0.05% cross-reactivity with recombinant human (rh) CCL16, rhCCL8, rhCCL7, rhCCL4, and rhCCL3 is observed.


目次に戻る

Applications and Data

 Recommended
Concentration
Sample
Western Blot0.1 µg/mLRecombinant Human CCL14a/HCC‑1 aa 20-93 (Catalog # 324-HC)
Human CCL14a/HCC-1 Sandwich ImmunoassayReagent
ELISA Capture (Matched Antibody Pair)2-8 µg/mL Human CCL14/HCC‑1/HCC‑3 Antibody (Catalog #MAB3241 )
ELISA Detection (Matched Antibody Pair)0.1-0.4 µg/mL Human CCL14a/HCC‑1 Biotinylated Antibody (Catalog #BAF324 )
ELISA Standard  Recombinant Human CCL14a/HCC-1 Protein (Catalog #324-HC )
Please Note: Optimal dilutions should be determined by each laboratory for each application.General Protocolsare available in the Technical Information section on our website.Preparation and Storage
ReconstitutionReconstitute at 0.2 mg/mL in sterile PBS.Reconstitution Buffer Available
ShippingThe product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
Stability & StorageUse a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied.
1 month, 2 to 8 °C under sterile conditions after reconstitution.
6 months, -20 to -70 °C under sterile conditions after reconstitution.
Background: CCL14a/HCC-1

HCC-1 (Hemofiltrate CC Chemokine-1) was originally isolated from the hemofiltrate of human patients with chronic renal failure (1). It belongs to the CC chemokine superfamily and has been designated CCL14a. HCC-1/CCL14a cDNA encodes a 93 amino acid (aa) residue  precursor with a 19 aa signal peptide that is cleaved to form the 74 aa secreted protein (aa 20 - 93). By alternative splicing, a second longer isoform named HCC-3/CCL14b, which includes sequences from exon 3, also exists (2). HCC-1/CCL14a is expressed constitutively in various normal tissues including spleen, liver, muscle, gut and bone marrow. It circulates at nanomolar concentrations in human plasma. Different post-translationally modified HCC-1/CCL14a, including O-glycosylated and N-terminally truncated variants of HCC-1/CCL14a, have been identified (3, 4). Whereas the 74 aa peptide is a weak CCR1 agonist, the proteolytically processed, truncated HCC-1/CCL14a (aa 28 - 93) is a highly potent agonist of CCR1, CCR5 and to a lesser extent, CCR3. HCC-1/CCL14a (aa 28 - 93) promotes chemotaxis of T lymphocytes, monocytes and eosinophils, and inhibits infection of M-tropic human immunodeficiency virus type 1. Activation of the HCC-1/CCL14a precursor to active peptide is mediated by the urokinase type plasminogen activator or plasmin (5).

目次に戻る

References

Schulz-Knappe, P. et al. (1996) J. Exp. Med. 183:295.
Forssmanns, U. et al. (2001) J. Leukocyte Biology 70:357.
Richter, R. et al. (2000) Biochemistry 39:10799.
Munch, J. et al. (2002) Antimicrob. Agents Chemother. 46:982.
Vakili, J. et al. (2001) J. Immunol. 167:3406.
Entrez Gene IDs:6358 (Human)
Alternate Names:CCL14; CCL14a; HCC1; HCC-1

目次に戻る

Related Research Areas

CC Chemokines and Receptors
Chemokines and Receptors
  1. Recognition versus adaptive up-regulation and degradation of CC chemokines by the chemokine decoy receptor D6 are determined by their N-terminal sequence.
    Authors: Savino B, Borroni EM, Torres NM, Proost P, Struyf S, Mortier A, Mantovani A, Locati M, Bonecchi R
    J. Biol. Chem., 2009;284(38):26207-15.
    Species: Human
    Sample Type: Cell Lysates
    Application: WB


目次に戻る

Related Product & Information

BackgroundCCL14a/HCC-1
background_contentBackground:
CCL14a/HCC-1
HCC-1 (Hemofiltrate CC Chemokine-1) was originally isolated from the hemofiltrate of human patients with chronic renal failure (1). It belongs to the CC chemokine superfamily and has been designated CCL14a. HCC-1/CCL14a cDNA encodes a 93 amino acid (aa) residue  precursor with a 19 aa signal peptide that is cleaved to form the 74 aa secreted protein (aa 20 - 93). By alternative splicing, a second longer isoform named HCC-3/CCL14b, which includes sequences from exon 3, also exists (2). HCC-1/CCL14a is expressed constitutively in various normal tissues including spleen, liver, muscle, gut and bone marrow. It circulates at nanomolar concentrations in human plasma. Different post-translationally modified HCC-1/CCL14a, including O-glycosylated and N-terminally truncated variants of HCC-1/CCL14a, have been identified (3, 4). Whereas the 74 aa peptide is a weak CCR1 agonist, the proteolytically processed, truncated HCC-1/CCL14a (aa 28 - 93) is a highly potent agonist of CCR1, CCR5 and to a lesser extent, CCR3. HCC-1/CCL14a (aa 28 - 93) promotes chemotaxis of T lymphocytes, monocytes and eosinophils, and inhibits infection of M-tropic human immunodeficiency virus type 1. Activation of the HCC-1/CCL14a precursor to active peptide is mediated by the urokinase type plasminogen activator or plasmin (5).


目次に戻る

Citations

R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.
  1. Recognition versus adaptive up-regulation and degradation of CC chemokines by the chemokine decoy receptor D6 are determined by their N-terminal sequence.
    Authors: Savino B, Borroni EM, Torres NM, Proost P, Struyf S, Mortier A, Mantovani A, Locati M, Bonecchi R
    J. Biol. Chem., 2009;284(38):26207-15.
    Species: Human
    Sample Type: Cell Lysates
    Application: WB



目次に戻る

お問い合わせ先

(テクニカルサポート 試薬担当)

reagent@funakoshi.co.jp

製品情報は掲載時点のものですが、価格表内の価格については随時最新のものに更新されます。お問い合わせいただくタイミングにより製品情報・価格などは変更されている場合があります。
表示価格に、消費税等は含まれていません。一部価格が予告なく変更される場合がありますので、あらかじめご了承下さい。